In 2024, GSK completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, GSK has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GSK’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2024, the total operational greenhouse gas (GHG) emissions of GSK amounted to 755,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of GSK decreased by 8.04%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2024, the total Scope 1 emissions of GSK were 521,000 metric tons of CO₂ equivalent (tCO₂e). a
Since 2020, GSK's Scope 1 emissions have decreased by 26.72%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), GSK's Scope 1 emissions decreased by 10.33%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
In 2024, GSK reported Scope 2 greenhouse gas (GHG) emissions of 44,000 tCO₂e using the market-based method and 234,000 tCO₂e using the location-based method. a
Since 2020, GSK's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 24.27%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), GSK's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that GSK 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2024, GSK reported its Scope 2 emissions using the market-based method and using the location-based method. a